Zenicor – ESG risk research and ESG rating

We at sustainAX have ESG risk researched and ESG risk rated Zenicor and our clients can access the reseach on their Bloomberg terminals.

Zenicor is in the materiality based sector of TECHNOLOGY HARDWARE AND EQUIPMENT, TELECOMMUNICATION SERVICES.

What the company say about themselves:

Zenicor Medical Systems AB is a Swedish medical technology company that is a leader in early diagnosis of arrhythmias and stroke prevention for healthcare. The company was founded in 2003 and has thus been active in the field for 20 years, which means that we are one of the pioneers leading the development in the diagnosis of atrial fibrillation. Zenicor works actively to develop the chain of care for early diagnosis. Together with researchers and healthcare professionals, Zenicor has developed a complete solution – Zenicor ECG – which enables a simple and cost-effective method for finding and diagnosing atrial fibrillation and other heart rhythm disorders. - Zenicor conducts its own research and development of systems and products with the objective of ensuring continued internationally competitive solutions in the long term. Sales, training, technical support and service are primarily handled by Zenicor's own employees. Manufacturing takes place at the company's Swedish partner Orbit One.

Are you interested in the ESG research and ESG rating?

If you are interested in the ESG risk research and ESG risk rating of Zenicor, contact us at sustainAX

Generated by MPG